nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—CYP2C19—Methimazole—Graves' disease	0.183	0.546	CbGbCtD
Indomethacin—CYP2C9—Methimazole—Graves' disease	0.152	0.454	CbGbCtD
Indomethacin—Nephritis—Methimazole—Graves' disease	0.0387	0.0972	CcSEcCtD
Indomethacin—Epigastric distress—Methimazole—Graves' disease	0.0341	0.0856	CcSEcCtD
Indomethacin—Nephritis—Propylthiouracil—Graves' disease	0.0329	0.0826	CcSEcCtD
Indomethacin—Epigastric distress—Propylthiouracil—Graves' disease	0.029	0.0728	CcSEcCtD
Indomethacin—Erythema nodosum—Propylthiouracil—Graves' disease	0.026	0.0653	CcSEcCtD
Indomethacin—Aplastic anaemia—Methimazole—Graves' disease	0.0124	0.0312	CcSEcCtD
Indomethacin—Vasculitis—Propylthiouracil—Graves' disease	0.0115	0.0289	CcSEcCtD
Indomethacin—Aplastic anaemia—Propylthiouracil—Graves' disease	0.0106	0.0265	CcSEcCtD
Indomethacin—PTGR2—pituitary gland—Graves' disease	0.00921	0.0477	CbGeAlD
Indomethacin—PTGR2—adipose tissue—Graves' disease	0.00917	0.0475	CbGeAlD
Indomethacin—Dermatitis exfoliative—Propylthiouracil—Graves' disease	0.00866	0.0217	CcSEcCtD
Indomethacin—PTGR2—thyroid gland—Graves' disease	0.00794	0.0412	CbGeAlD
Indomethacin—GLO1—eye—Graves' disease	0.00766	0.0397	CbGeAlD
Indomethacin—Drowsiness—Methimazole—Graves' disease	0.0074	0.0186	CcSEcCtD
Indomethacin—Neuropathy peripheral—Methimazole—Graves' disease	0.00726	0.0182	CcSEcCtD
Indomethacin—Jaundice—Methimazole—Graves' disease	0.00722	0.0181	CcSEcCtD
Indomethacin—ABCC6—eye—Graves' disease	0.00705	0.0366	CbGeAlD
Indomethacin—Agranulocytosis—Methimazole—Graves' disease	0.00691	0.0173	CcSEcCtD
Indomethacin—PLA2G2A—connective tissue—Graves' disease	0.00686	0.0356	CbGeAlD
Indomethacin—ABCC6—connective tissue—Graves' disease	0.00679	0.0352	CbGeAlD
Indomethacin—PPARA—eye—Graves' disease	0.00665	0.0345	CbGeAlD
Indomethacin—Hepatitis—Methimazole—Graves' disease	0.00665	0.0167	CcSEcCtD
Indomethacin—PPARA—connective tissue—Graves' disease	0.00641	0.0332	CbGeAlD
Indomethacin—Drowsiness—Propylthiouracil—Graves' disease	0.0063	0.0158	CcSEcCtD
Indomethacin—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.00617	0.0155	CcSEcCtD
Indomethacin—Jaundice—Propylthiouracil—Graves' disease	0.00614	0.0154	CcSEcCtD
Indomethacin—Agranulocytosis—Propylthiouracil—Graves' disease	0.00588	0.0147	CcSEcCtD
Indomethacin—Alopecia—Methimazole—Graves' disease	0.00587	0.0147	CcSEcCtD
Indomethacin—GLO1—pituitary gland—Graves' disease	0.00569	0.0295	CbGeAlD
Indomethacin—Haemoglobin—Propylthiouracil—Graves' disease	0.00568	0.0142	CcSEcCtD
Indomethacin—GLO1—adipose tissue—Graves' disease	0.00566	0.0294	CbGeAlD
Indomethacin—Haemorrhage—Propylthiouracil—Graves' disease	0.00565	0.0142	CcSEcCtD
Indomethacin—Hepatitis—Propylthiouracil—Graves' disease	0.00565	0.0142	CcSEcCtD
Indomethacin—PLA2G2A—pituitary gland—Graves' disease	0.00529	0.0274	CbGeAlD
Indomethacin—PLA2G2A—adipose tissue—Graves' disease	0.00527	0.0273	CbGeAlD
Indomethacin—CXCL8—pituitary gland—Graves' disease	0.00523	0.0271	CbGeAlD
Indomethacin—CXCL8—adipose tissue—Graves' disease	0.00521	0.027	CbGeAlD
Indomethacin—ABCC6—adipose tissue—Graves' disease	0.00521	0.027	CbGeAlD
Indomethacin—Vertigo—Methimazole—Graves' disease	0.0052	0.013	CcSEcCtD
Indomethacin—Leukopenia—Methimazole—Graves' disease	0.00518	0.013	CcSEcCtD
Indomethacin—PTGDR2—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.0051	0.0688	CbGpPWpGaD
Indomethacin—Alopecia—Propylthiouracil—Graves' disease	0.00499	0.0125	CcSEcCtD
Indomethacin—PPARA—adipose tissue—Graves' disease	0.00492	0.0255	CbGeAlD
Indomethacin—GLO1—thyroid gland—Graves' disease	0.0049	0.0254	CbGeAlD
Indomethacin—CES1—connective tissue—Graves' disease	0.00476	0.0247	CbGeAlD
Indomethacin—Oedema—Methimazole—Graves' disease	0.00472	0.0118	CcSEcCtD
Indomethacin—Thrombocytopenia—Methimazole—Graves' disease	0.00462	0.0116	CcSEcCtD
Indomethacin—PLA2G2A—thyroid gland—Graves' disease	0.00456	0.0236	CbGeAlD
Indomethacin—ABCC6—thyroid gland—Graves' disease	0.00451	0.0234	CbGeAlD
Indomethacin—Vertigo—Propylthiouracil—Graves' disease	0.00442	0.0111	CcSEcCtD
Indomethacin—Leukopenia—Propylthiouracil—Graves' disease	0.0044	0.011	CcSEcCtD
Indomethacin—PPARA—thyroid gland—Graves' disease	0.00426	0.0221	CbGeAlD
Indomethacin—Paraesthesia—Methimazole—Graves' disease	0.00424	0.0106	CcSEcCtD
Indomethacin—Somnolence—Methimazole—Graves' disease	0.0042	0.0105	CcSEcCtD
Indomethacin—Dyspepsia—Methimazole—Graves' disease	0.00416	0.0104	CcSEcCtD
Indomethacin—AKR1C3—pituitary gland—Graves' disease	0.0041	0.0213	CbGeAlD
Indomethacin—AKR1C3—adipose tissue—Graves' disease	0.00409	0.0212	CbGeAlD
Indomethacin—Oedema—Propylthiouracil—Graves' disease	0.00402	0.0101	CcSEcCtD
Indomethacin—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00393	0.00986	CcSEcCtD
Indomethacin—Urticaria—Methimazole—Graves' disease	0.00375	0.00941	CcSEcCtD
Indomethacin—Body temperature increased—Methimazole—Graves' disease	0.00373	0.00936	CcSEcCtD
Indomethacin—CES1—adipose tissue—Graves' disease	0.00365	0.0189	CbGeAlD
Indomethacin—Paraesthesia—Propylthiouracil—Graves' disease	0.00361	0.00904	CcSEcCtD
Indomethacin—Somnolence—Propylthiouracil—Graves' disease	0.00357	0.00895	CcSEcCtD
Indomethacin—AKR1C3—thyroid gland—Graves' disease	0.00354	0.0183	CbGeAlD
Indomethacin—Dyspepsia—Propylthiouracil—Graves' disease	0.00353	0.00886	CcSEcCtD
Indomethacin—PPARG—connective tissue—Graves' disease	0.00353	0.0183	CbGeAlD
Indomethacin—Pruritus—Methimazole—Graves' disease	0.00334	0.00838	CcSEcCtD
Indomethacin—SLC22A8—eye—Graves' disease	0.0033	0.0171	CbGeAlD
Indomethacin—Urticaria—Propylthiouracil—Graves' disease	0.00319	0.008	CcSEcCtD
Indomethacin—Body temperature increased—Propylthiouracil—Graves' disease	0.00317	0.00796	CcSEcCtD
Indomethacin—CES1—thyroid gland—Graves' disease	0.00316	0.0164	CbGeAlD
Indomethacin—Vomiting—Methimazole—Graves' disease	0.003	0.00753	CcSEcCtD
Indomethacin—Rash—Methimazole—Graves' disease	0.00298	0.00747	CcSEcCtD
Indomethacin—ABCC3—adipose tissue—Graves' disease	0.00298	0.0154	CbGeAlD
Indomethacin—Dermatitis—Methimazole—Graves' disease	0.00297	0.00746	CcSEcCtD
Indomethacin—Headache—Methimazole—Graves' disease	0.00296	0.00742	CcSEcCtD
Indomethacin—Pruritus—Propylthiouracil—Graves' disease	0.00284	0.00712	CcSEcCtD
Indomethacin—Nausea—Methimazole—Graves' disease	0.00281	0.00703	CcSEcCtD
Indomethacin—PPARG—adipose tissue—Graves' disease	0.0027	0.014	CbGeAlD
Indomethacin—ABCC3—thyroid gland—Graves' disease	0.00258	0.0134	CbGeAlD
Indomethacin—Vomiting—Propylthiouracil—Graves' disease	0.00255	0.0064	CcSEcCtD
Indomethacin—Rash—Propylthiouracil—Graves' disease	0.00253	0.00635	CcSEcCtD
Indomethacin—Dermatitis—Propylthiouracil—Graves' disease	0.00253	0.00634	CcSEcCtD
Indomethacin—Headache—Propylthiouracil—Graves' disease	0.00252	0.00631	CcSEcCtD
Indomethacin—ABCC4—adipose tissue—Graves' disease	0.00246	0.0127	CbGeAlD
Indomethacin—Nausea—Propylthiouracil—Graves' disease	0.00239	0.00598	CcSEcCtD
Indomethacin—PPARG—thyroid gland—Graves' disease	0.00234	0.0121	CbGeAlD
Indomethacin—ABCC4—thyroid gland—Graves' disease	0.00213	0.011	CbGeAlD
Indomethacin—ABCC1—pituitary gland—Graves' disease	0.0021	0.0109	CbGeAlD
Indomethacin—ABCC1—adipose tissue—Graves' disease	0.00209	0.0109	CbGeAlD
Indomethacin—PTGS1—connective tissue—Graves' disease	0.00188	0.00977	CbGeAlD
Indomethacin—ABCC1—thyroid gland—Graves' disease	0.00181	0.0094	CbGeAlD
Indomethacin—PTGS2—connective tissue—Graves' disease	0.0018	0.00934	CbGeAlD
Indomethacin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SCGB3A2—Graves' disease	0.00176	0.0238	CbGpPWpGaD
Indomethacin—PTGS1—pituitary gland—Graves' disease	0.00145	0.00753	CbGeAlD
Indomethacin—PTGS1—adipose tissue—Graves' disease	0.00145	0.0075	CbGeAlD
Indomethacin—PPARA—Orphan transporters—GABRA3—Graves' disease	0.00142	0.0192	CbGpPWpGaD
Indomethacin—PTGS2—pituitary gland—Graves' disease	0.00139	0.0072	CbGeAlD
Indomethacin—PTGS2—adipose tissue—Graves' disease	0.00138	0.00717	CbGeAlD
Indomethacin—PTGS1—thyroid gland—Graves' disease	0.00125	0.00649	CbGeAlD
Indomethacin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Graves' disease	0.00112	0.0151	CbGpPWpGaD
Indomethacin—ABCC11—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00102	0.0138	CbGpPWpGaD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000928	0.0125	CbGpPWpGaD
Indomethacin—CXCL8—Chemokine receptors bind chemokines—CXCL10—Graves' disease	0.000926	0.0125	CbGpPWpGaD
Indomethacin—PLA2G2A—Spinal Cord Injury—CXCL10—Graves' disease	0.000884	0.0119	CbGpPWpGaD
Indomethacin—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Graves' disease	0.000881	0.0119	CbGpPWpGaD
Indomethacin—ABCB1—pituitary gland—Graves' disease	0.000858	0.00445	CbGeAlD
Indomethacin—ABCB1—adipose tissue—Graves' disease	0.000855	0.00443	CbGeAlD
Indomethacin—CXCL8—TSLP Signaling Pathway—IL2RA—Graves' disease	0.000814	0.011	CbGpPWpGaD
Indomethacin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Graves' disease	0.000808	0.0109	CbGpPWpGaD
Indomethacin—CXCL8—Allograft Rejection—HLA-E—Graves' disease	0.000805	0.0109	CbGpPWpGaD
Indomethacin—CXCL8—Allograft Rejection—CD40—Graves' disease	0.000787	0.0106	CbGpPWpGaD
Indomethacin—ABCC6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000777	0.0105	CbGpPWpGaD
Indomethacin—CXCL8—Allograft Rejection—CTLA4—Graves' disease	0.000775	0.0105	CbGpPWpGaD
Indomethacin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Graves' disease	0.000775	0.0105	CbGpPWpGaD
Indomethacin—PTGDR2—G alpha (i) signalling events—CXCL10—Graves' disease	0.000754	0.0102	CbGpPWpGaD
Indomethacin—ABCB1—thyroid gland—Graves' disease	0.00074	0.00384	CbGeAlD
Indomethacin—CXCL8—Overview of nanoparticle effects—TNF—Graves' disease	0.000717	0.00968	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR ligand binding—TSHR—Graves' disease	0.000707	0.00954	CbGpPWpGaD
Indomethacin—CXCL8—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	0.000641	0.00865	CbGpPWpGaD
Indomethacin—CXCL8—Allograft Rejection—HLA-DQB1—Graves' disease	0.000638	0.00862	CbGpPWpGaD
Indomethacin—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Graves' disease	0.000637	0.00859	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000619	0.00835	CbGpPWpGaD
Indomethacin—CXCL8—EBV LMP1 signaling—TNF—Graves' disease	0.000616	0.00831	CbGpPWpGaD
Indomethacin—PPARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—Graves' disease	0.000614	0.00828	CbGpPWpGaD
Indomethacin—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Graves' disease	0.00061	0.00824	CbGpPWpGaD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.0006	0.0081	CbGpPWpGaD
Indomethacin—PLA2G2A—Spinal Cord Injury—ICAM1—Graves' disease	0.000586	0.00791	CbGpPWpGaD
Indomethacin—CXCL8—AP-1 transcription factor network—HLA-A—Graves' disease	0.000585	0.0079	CbGpPWpGaD
Indomethacin—CXCL8—Allograft Rejection—HLA-B—Graves' disease	0.000573	0.00774	CbGpPWpGaD
Indomethacin—CXCL8—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	0.000573	0.00773	CbGpPWpGaD
Indomethacin—CXCL8—Allograft Rejection—FASLG—Graves' disease	0.000561	0.00756	CbGpPWpGaD
Indomethacin—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—Graves' disease	0.000547	0.00739	CbGpPWpGaD
Indomethacin—CXCL8—Allograft Rejection—FAS—Graves' disease	0.00054	0.00729	CbGpPWpGaD
Indomethacin—CXCL8—Allograft Rejection—IL2RA—Graves' disease	0.000537	0.00725	CbGpPWpGaD
Indomethacin—PLA2G2A—Cardiac Hypertrophic Response—TNF—Graves' disease	0.000532	0.00717	CbGpPWpGaD
Indomethacin—CXCL8—Allograft Rejection—HLA-A—Graves' disease	0.000531	0.00717	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000526	0.0071	CbGpPWpGaD
Indomethacin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Graves' disease	0.000525	0.00708	CbGpPWpGaD
Indomethacin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000511	0.0069	CbGpPWpGaD
Indomethacin—CXCL8—Spinal Cord Injury—CXCL10—Graves' disease	0.00051	0.00688	CbGpPWpGaD
Indomethacin—PPARG—Transcription factor regulation in adipogenesis—TNF—Graves' disease	0.000503	0.00678	CbGpPWpGaD
Indomethacin—CXCL8—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	0.000501	0.00676	CbGpPWpGaD
Indomethacin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Graves' disease	0.00049	0.00661	CbGpPWpGaD
Indomethacin—CXCL8—Allograft Rejection—HLA-DRB1—Graves' disease	0.000485	0.00655	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR ligand binding—CXCL10—Graves' disease	0.000457	0.00617	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000453	0.00611	CbGpPWpGaD
Indomethacin—CXCL8—Glucocorticoid receptor regulatory network—ICAM1—Graves' disease	0.000452	0.0061	CbGpPWpGaD
Indomethacin—CXCL8—ATF-2 transcription factor network—IFNG—Graves' disease	0.000448	0.00604	CbGpPWpGaD
Indomethacin—CXCL8—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	0.000447	0.00604	CbGpPWpGaD
Indomethacin—PLA2G2A—Spinal Cord Injury—IFNG—Graves' disease	0.000446	0.00602	CbGpPWpGaD
Indomethacin—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Graves' disease	0.00044	0.00593	CbGpPWpGaD
Indomethacin—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000403	0.00543	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—TSHR—Graves' disease	0.0004	0.00539	CbGpPWpGaD
Indomethacin—PPARA—Adipogenesis—FAS—Graves' disease	0.000399	0.00538	CbGpPWpGaD
Indomethacin—PLA2G2A—Spinal Cord Injury—IL1B—Graves' disease	0.000398	0.00537	CbGpPWpGaD
Indomethacin—PTGS1—Overview of nanoparticle effects—TNF—Graves' disease	0.000396	0.00534	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000392	0.0053	CbGpPWpGaD
Indomethacin—CXCL8—AP-1 transcription factor network—IFNG—Graves' disease	0.000391	0.00527	CbGpPWpGaD
Indomethacin—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.000379	0.00511	CbGpPWpGaD
Indomethacin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	0.00037	0.00499	CbGpPWpGaD
Indomethacin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	0.00037	0.00499	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—TSHR—Graves' disease	0.000363	0.0049	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000362	0.00488	CbGpPWpGaD
Indomethacin—CXCL8—Allograft Rejection—IFNG—Graves' disease	0.000355	0.00478	CbGpPWpGaD
Indomethacin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Graves' disease	0.000354	0.00478	CbGpPWpGaD
Indomethacin—CXCL8—Peptide ligand-binding receptors—CXCL10—Graves' disease	0.000348	0.0047	CbGpPWpGaD
Indomethacin—PPARA—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000347	0.00468	CbGpPWpGaD
Indomethacin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Graves' disease	0.000346	0.00467	CbGpPWpGaD
Indomethacin—CXCL8—Glucocorticoid receptor regulatory network—IFNG—Graves' disease	0.000344	0.00464	CbGpPWpGaD
Indomethacin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Graves' disease	0.000339	0.00458	CbGpPWpGaD
Indomethacin—SLC22A11—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000338	0.00456	CbGpPWpGaD
Indomethacin—CXCL8—Spinal Cord Injury—ICAM1—Graves' disease	0.000338	0.00456	CbGpPWpGaD
Indomethacin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000331	0.00447	CbGpPWpGaD
Indomethacin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	0.00033	0.00445	CbGpPWpGaD
Indomethacin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	0.00033	0.00445	CbGpPWpGaD
Indomethacin—CXCL8—Allograft Rejection—IL1B—Graves' disease	0.000316	0.00427	CbGpPWpGaD
Indomethacin—PTGS2—Overview of nanoparticle effects—TNF—Graves' disease	0.000314	0.00424	CbGpPWpGaD
Indomethacin—SLC22A7—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000307	0.00414	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000297	0.00401	CbGpPWpGaD
Indomethacin—CXCL8—G alpha (i) signalling events—CXCL10—Graves' disease	0.000294	0.00397	CbGpPWpGaD
Indomethacin—PLA2G2A—Spinal Cord Injury—TNF—Graves' disease	0.000289	0.0039	CbGpPWpGaD
Indomethacin—PPARG—Adipogenesis—FAS—Graves' disease	0.000286	0.00386	CbGpPWpGaD
Indomethacin—CXCL8—Senescence and Autophagy in Cancer—IFNG—Graves' disease	0.000282	0.00381	CbGpPWpGaD
Indomethacin—PPARA—Circadian rythm related genes—FAS—Graves' disease	0.000281	0.0038	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000281	0.0038	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—GC—Graves' disease	0.000276	0.00372	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—TSHR—Graves' disease	0.000275	0.00372	CbGpPWpGaD
Indomethacin—ABCC3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000263	0.00355	CbGpPWpGaD
Indomethacin—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000261	0.00352	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000259	0.0035	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—CXCL10—Graves' disease	0.000258	0.00348	CbGpPWpGaD
Indomethacin—SLC22A8—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000258	0.00348	CbGpPWpGaD
Indomethacin—CXCL8—Toll-like Receptor Signaling Pathway—IL1B—Graves' disease	0.000258	0.00348	CbGpPWpGaD
Indomethacin—PPARA—Transcriptional regulation of white adipocyte differentiation—TNF—Graves' disease	0.000257	0.00347	CbGpPWpGaD
Indomethacin—CXCL8—Spinal Cord Injury—IFNG—Graves' disease	0.000257	0.00347	CbGpPWpGaD
Indomethacin—CXCL8—Senescence and Autophagy in Cancer—IL1B—Graves' disease	0.000252	0.0034	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—HLA-E—Graves' disease	0.00025	0.00337	CbGpPWpGaD
Indomethacin—ABCC4—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000247	0.00334	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—CD40—Graves' disease	0.000244	0.0033	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000242	0.00326	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—CTLA4—Graves' disease	0.000241	0.00325	CbGpPWpGaD
Indomethacin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	0.000239	0.00323	CbGpPWpGaD
Indomethacin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	0.000239	0.00323	CbGpPWpGaD
Indomethacin—PTGS1—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000236	0.00318	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—CXCL10—Graves' disease	0.000234	0.00316	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—GC—Graves' disease	0.000234	0.00316	CbGpPWpGaD
Indomethacin—ALB—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.000234	0.00316	CbGpPWpGaD
Indomethacin—CXCL8—Metabolism of proteins—B3GNT2—Graves' disease	0.000234	0.00316	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000234	0.00315	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000233	0.00315	CbGpPWpGaD
Indomethacin—CXCL8—Allograft Rejection—TNF—Graves' disease	0.000229	0.0031	CbGpPWpGaD
Indomethacin—CXCL8—Spinal Cord Injury—IL1B—Graves' disease	0.000229	0.0031	CbGpPWpGaD
Indomethacin—SLCO1A2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000229	0.00309	CbGpPWpGaD
Indomethacin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000224	0.00302	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—CXCL10—Graves' disease	0.000223	0.00302	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000221	0.00299	CbGpPWpGaD
Indomethacin—SLC22A6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000215	0.0029	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TSHR—Graves' disease	0.000214	0.00289	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—B3GNT2—Graves' disease	0.000209	0.00282	CbGpPWpGaD
Indomethacin—ABCC2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000208	0.00281	CbGpPWpGaD
Indomethacin—ABCC1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000206	0.00278	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—FAS—Graves' disease	0.000202	0.00272	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—GC—Graves' disease	0.000202	0.00272	CbGpPWpGaD
Indomethacin—CXCL8—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	0.000201	0.00272	CbGpPWpGaD
Indomethacin—PPARG—Signaling events mediated by HDAC Class I—TNF—Graves' disease	0.000199	0.00269	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—HLA-DQB1—Graves' disease	0.000198	0.00268	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—IL2RA—Graves' disease	0.000197	0.00266	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000197	0.00266	CbGpPWpGaD
Indomethacin—SLCO1B1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000196	0.00264	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—ICAM1—Graves' disease	0.000191	0.00257	CbGpPWpGaD
Indomethacin—PTGS2—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000187	0.00253	CbGpPWpGaD
Indomethacin—CXCL8—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.000187	0.00252	CbGpPWpGaD
Indomethacin—ABCC4—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000185	0.00249	CbGpPWpGaD
Indomethacin—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—Graves' disease	0.000185	0.00249	CbGpPWpGaD
Indomethacin—CXCL8—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000183	0.00248	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—B3GNT2—Graves' disease	0.000182	0.00246	CbGpPWpGaD
Indomethacin—PTGS1—Selenium Micronutrient Network—IFNG—Graves' disease	0.000179	0.00242	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—IL2RA—Graves' disease	0.000179	0.00242	CbGpPWpGaD
Indomethacin—ALB—Vitamin B12 Metabolism—IFNG—Graves' disease	0.000178	0.00241	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—HLA-B—Graves' disease	0.000178	0.0024	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—CXCL10—Graves' disease	0.000178	0.0024	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—B3GNT2—Graves' disease	0.000178	0.0024	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—GC—Graves' disease	0.000175	0.00236	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—FASLG—Graves' disease	0.000174	0.00235	CbGpPWpGaD
Indomethacin—PPARA—Adipogenesis—TNF—Graves' disease	0.000169	0.00229	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—FAS—Graves' disease	0.000168	0.00227	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—IL2RA—Graves' disease	0.000167	0.00225	CbGpPWpGaD
Indomethacin—CXCL8—Spinal Cord Injury—TNF—Graves' disease	0.000166	0.00225	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—HLA-A—Graves' disease	0.000165	0.00223	CbGpPWpGaD
Indomethacin—PTGS1—Selenium Micronutrient Network—IL1B—Graves' disease	0.00016	0.00216	CbGpPWpGaD
Indomethacin—ALB—Vitamin B12 Metabolism—IL1B—Graves' disease	0.000159	0.00215	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000156	0.00211	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—TSHR—Graves' disease	0.000156	0.0021	CbGpPWpGaD
Indomethacin—PTGS2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	0.000155	0.00209	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—B3GNT2—Graves' disease	0.000153	0.00206	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000151	0.00204	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—HLA-DRB1—Graves' disease	0.000151	0.00203	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—ICAM1—Graves' disease	0.000148	0.002	CbGpPWpGaD
Indomethacin—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	0.000146	0.00197	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—IFNG—Graves' disease	0.000145	0.00196	CbGpPWpGaD
Indomethacin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000145	0.00196	CbGpPWpGaD
Indomethacin—PTGS2—C-MYB transcription factor network—CD4—Graves' disease	0.000143	0.00193	CbGpPWpGaD
Indomethacin—PTGS2—Selenium Micronutrient Network—IFNG—Graves' disease	0.000142	0.00192	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—TSHR—Graves' disease	0.000141	0.00191	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CXCL10—Graves' disease	0.000138	0.00187	CbGpPWpGaD
Indomethacin—CXCL8—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000133	0.0018	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—B3GNT2—Graves' disease	0.000132	0.00179	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—GC—Graves' disease	0.000132	0.00179	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—GC—Graves' disease	0.000132	0.00179	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—IL1B—Graves' disease	0.000129	0.00175	CbGpPWpGaD
Indomethacin—PTGS2—Selenium Micronutrient Network—IL1B—Graves' disease	0.000127	0.00171	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000127	0.00171	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—GC—Graves' disease	0.000125	0.00169	CbGpPWpGaD
Indomethacin—PPARG—Adipogenesis—TNF—Graves' disease	0.000121	0.00164	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000121	0.00164	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000117	0.00158	CbGpPWpGaD
Indomethacin—PTGS1—Selenium Micronutrient Network—TNF—Graves' disease	0.000116	0.00157	CbGpPWpGaD
Indomethacin—ALB—Vitamin B12 Metabolism—TNF—Graves' disease	0.000115	0.00156	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—GC—Graves' disease	0.000115	0.00156	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—IFNG—Graves' disease	0.000115	0.00156	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000114	0.00153	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—IFNG—Graves' disease	0.000113	0.00152	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000112	0.00151	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—IFNG—Graves' disease	0.00011	0.00149	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—GC—Graves' disease	0.000108	0.00145	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—GC—Graves' disease	0.000108	0.00145	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TSHR—Graves' disease	0.000106	0.00143	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—IL2RA—Graves' disease	0.000106	0.00143	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—GC—Graves' disease	0.000104	0.0014	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000104	0.0014	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—IL1B—Graves' disease	0.000103	0.00139	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—CXCL10—Graves' disease	0.000101	0.00136	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—IL1B—Graves' disease	0.0001	0.00136	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—B3GNT2—Graves' disease	0.0001	0.00135	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—B3GNT2—Graves' disease	0.0001	0.00135	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—GC—Graves' disease	9.86e-05	0.00133	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—IL1B—Graves' disease	9.82e-05	0.00133	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	9.8e-05	0.00132	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—IL2RA—Graves' disease	9.53e-05	0.00129	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—B3GNT2—Graves' disease	9.49e-05	0.00128	CbGpPWpGaD
Indomethacin—ABCC1—Disease—B3GNT2—Graves' disease	9.39e-05	0.00127	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—TNF—Graves' disease	9.39e-05	0.00127	CbGpPWpGaD
Indomethacin—PTGS2—Selenium Micronutrient Network—TNF—Graves' disease	9.22e-05	0.00124	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—CXCL10—Graves' disease	9.13e-05	0.00123	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GC—Graves' disease	8.77e-05	0.00118	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—B3GNT2—Graves' disease	8.74e-05	0.00118	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	8.59e-05	0.00116	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	8.36e-05	0.00113	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TSHR—Graves' disease	8.35e-05	0.00113	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	8.28e-05	0.00112	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—B3GNT2—Graves' disease	8.16e-05	0.0011	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—B3GNT2—Graves' disease	8.16e-05	0.0011	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—B3GNT2—Graves' disease	7.87e-05	0.00106	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—IL2RA—Graves' disease	7.69e-05	0.00104	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—B3GNT2—Graves' disease	7.47e-05	0.00101	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—TNF—Graves' disease	7.46e-05	0.00101	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—HLA-A—Graves' disease	7.38e-05	0.000996	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—TNF—Graves' disease	7.29e-05	0.000984	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—TNF—Graves' disease	7.13e-05	0.000962	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL2RA—Graves' disease	6.98e-05	0.000942	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GC—Graves' disease	6.97e-05	0.00094	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CXCL10—Graves' disease	6.84e-05	0.000923	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—B3GNT2—Graves' disease	6.65e-05	0.000897	CbGpPWpGaD
Indomethacin—PTGS2—Disease—B3GNT2—Graves' disease	6.3e-05	0.000851	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—TNF—Graves' disease	5.82e-05	0.000785	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GC—Graves' disease	5.64e-05	0.000761	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CXCL10—Graves' disease	5.4e-05	0.000728	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—B3GNT2—Graves' disease	5.28e-05	0.000712	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL2RA—Graves' disease	5.23e-05	0.000706	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GC—Graves' disease	5.06e-05	0.000683	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	4.96e-05	0.000669	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GC—Graves' disease	4.94e-05	0.000666	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—CD4—Graves' disease	4.76e-05	0.000642	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GC—Graves' disease	4.61e-05	0.000623	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IL2RA—Graves' disease	4.31e-05	0.000582	CbGpPWpGaD
Indomethacin—ALB—Metabolism—B3GNT2—Graves' disease	4.27e-05	0.000576	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—TNF—Graves' disease	4.17e-05	0.000563	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL2RA—Graves' disease	4.12e-05	0.000557	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—B3GNT2—Graves' disease	3.83e-05	0.000517	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HLA-A—Graves' disease	3.8e-05	0.000513	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—B3GNT2—Graves' disease	3.74e-05	0.000505	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	3.52e-05	0.000475	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—B3GNT2—Graves' disease	3.5e-05	0.000472	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HLA-A—Graves' disease	2.55e-05	0.000344	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CD4—Graves' disease	2.45e-05	0.000331	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD4—Graves' disease	1.64e-05	0.000222	CbGpPWpGaD
